Henry Schein (NASDAQ:HSIC) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Henry Schein (NASDAQ:HSIC - Get Free Report) posted its quarterly earnings results on Monday. The company reported $1.15 EPS for the quarter, topping analysts' consensus estimates of $1.11 by $0.04, RTT News reports. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. During the same quarter in the previous year, the company posted $1.10 earnings per share. Henry Schein updated its FY 2025 guidance to 4.800-4.940 EPS.

Henry Schein Price Performance

Shares of HSIC opened at $65.30 on Monday. The business has a 50-day moving average of $68.01 and a 200-day moving average of $71.59. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company has a market capitalization of $8.00 billion, a price-to-earnings ratio of 26.87, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. Henry Schein has a 1 year low of $60.56 and a 1 year high of $82.49.

Analyst Ratings Changes

A number of research analysts have recently commented on HSIC shares. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and increased their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Jefferies Financial Group increased their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. UBS Group decreased their target price on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 26th. StockNews.com cut Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Finally, Wells Fargo & Company assumed coverage on Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price objective on the stock. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $80.20.

Insider Activity at Henry Schein

In other news, CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. The trade was a 6.05 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now directly owns 24,805 shares of the company's stock, valued at $1,762,147.20. This represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.